Bolin Geng
10Patents
4h-index
28Co-inventors
56Inventor score
Filing activity: Jun 16, 2006 → Dec 17, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8124602B2 | Compounds for the treatment of multi-drug resistant bacterial infections | Chemistry; Metallurgy | 10 | Active |
| US7875715B2 | Compounds for the treatment of multi-drug resistant bacterial infections | Chemistry; Metallurgy | 8 | Active |
| US9850262B2 | Proteasome activity enhancing compounds | Chemistry; Metallurgy | 4 | Active |
| US9309245B2 | Beta-lactamase inhibitor compounds | Emerging Cross-Sectional Technologies | 4 | Active |
| US10570119B2 | Inhibiting ataxia telangiectasia and Rad3-related protein (ATR) | Human Necessities | 2 | Active |
| US9623014B2 | β-lactamase inhibitor compounds | Emerging Cross-Sectional Technologies | 2 | Active |
| US11242361B2 | Proteasome activity enhancing compounds | Chemistry; Metallurgy | 1 | Active |
| US11028076B2 | Inhibiting ataxia telangiectasia and Rad3-related protein (ATR) | Human Necessities | 1 | Active |
| US11958873B2 | Proteasome activity enhancing compounds | Chemistry; Metallurgy | 0 | Active |
| US11787781B2 | Inhibiting ataxia telangiectasia and RAD3-related protein (ATR) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.